Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
US-10654813-B2 · May 19, 2020 · US
This patent family groups 5 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 39720243 |
| Family type | — |
| Earliest priority | Jan 10, 2008 |
| First filing country | US |
| Member publications | 5 |
| Countries | US |
| Representative publication | US10654813B2 — Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
Best representative member for this family based on priority and filing country.
US10654813B2 — Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies (published May 19, 2020)
Related publications in this family.
US-10654813-B2 · May 19, 2020 · US
US-2019022037-A1 · Jan 24, 2019 · US
US-10130595-B2 · Nov 20, 2018 · US
US-2016166519-A1 · Jun 16, 2016 · US
US-9233931-B2 · Jan 12, 2016 · US